CNTA vs PNW · $6.15B cap vs P/E 19, rev $2.61B
Centessa Pharmaceuticals PLC ADR (CNTA) versus Pinnacle West Capital Corp (PNW) — a side-by-side from cached financials, not a winner call.
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
Pinnacle West Capital Corp (PNW) is a utilities - regulated electric company listed on NYSE.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
Latest reported PNW revenue for 2026-06-30 was $2.61B. Net income was $215.9M. PNW currently screens at market cap $12.41B and trailing P/E 19.1.
CNTA currently screens at market cap $6.15B. PNW currently screens at market cap $12.41B and trailing P/E 19.1.
Not investment advice. Open the CNTA and PNW stock pages for the full models.
Not investment advice.